查詢結果分析
相關文獻
- Cytokeratin Fragment 19(Cyfra 21-1) as a Tumor Marker in Non-Small Cell Lung Cancer
- 非小細胞肺癌術前輔助性化學治療的經驗
- The Role of Radiotherapy for Advanced Non-Small Cell Lung Cancer
- Differential Display of mRNA in Human Lung Tissue and in Non-Small Cell Lung Cancer: A Preliminary Report
- 非小細胞肺癌的治療
- 晚期非小細胞肺癌之化學治療
- CA405之基因療法合併化學抗癌藥物對肺癌細胞之作用效果評估與機轉的探討(2)
- Treatment of Non-Small-Cell Lung Cancer: The Chinese Experience in a General Teaching Hospital
- erbB基因與非小細胞肺癌的原發抗藥性
- Concurrent 5-Fluorouracil, Leucovorin, Etoposide, Cisplatin and Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer
頁籤選單縮合
題名 | Cytokeratin Fragment 19(Cyfra 21-1) as a Tumor Marker in Non-Small Cell Lung Cancer=評估CYFRA 21-1作為非小細胞肺癌腫瘤標誌之價值 |
---|---|
作者 | 黃明賢; 鍾相彬; 林茂生; 鍾飲文; 蔡米山; 林秀純; 黃吉志; | 書刊名 | The Kaohsiung Journal of Medical Sciences |
卷期 | 12:2 1996.02[民85.02] |
頁次 | 頁62-68 |
分類號 | 416.224 |
關鍵詞 | 非小細胞肺癌; 腫瘤標誌; CYFRA 21-1; Non-small cell lung cancer; |
語文 | 英文(English) |